Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor.
Cancer Discovery
Piotrowska, Zofia Z; Niederst, Matthew J MJ; Karlovich, Chris A CA; Wakelee, Heather A HA; Neal, Joel W JW; Mino-Kenudson, Mari M; Fulton, Linnea L; Hata, Aaron N AN; Lockerman, Elizabeth L EL; Kalsy, Anuj A; Digumarthy, Subba S; Muzikansky, Alona A; Raponi, Mitch M; Garcia, Angel R AR; Mulvey, Hillary E HE; Parks, Melissa K MK; DiCecca, Richard H RH; Dias-Santagata, Dora D; Iafrate, A John AJ; Shaw, Alice T AT; Allen, Andrew R AR; Engelman, Jeffrey A JA; Sequist, Lecia V LV